Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages

Abhishek Dubey,1,* Dae Won Park,2,* Jung Eun Kwon,2 Yong Joon Jeong,2 Taegeun Kim,1 Inhye Kim,3 Se Chan Kang,2 Ki-Whan Chi1 1Department of Chemistry, University of Ulsan, Ulsan, 2Department of Life Science, Gachon University, Seongnam, 3Laboratory of Bio-Resources, Yongin-si, Gyeonggi-Do, Republic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dubey A, Park DW, Kwon JE, Jeong YJ, Kim T, Kim I, Kang SC, Chi KW
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/72a4d708df9c4fa78723bd37f44d1ccb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:72a4d708df9c4fa78723bd37f44d1ccb
record_format dspace
spelling oai:doaj.org-article:72a4d708df9c4fa78723bd37f44d1ccb2021-12-02T03:53:32ZInvestigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages1178-2013https://doaj.org/article/72a4d708df9c4fa78723bd37f44d1ccb2015-09-01T00:00:00Zhttp://www.dovepress.com/investigation-of-the-biological-and-anti-cancer-properties-of-ellagic--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Abhishek Dubey,1,* Dae Won Park,2,* Jung Eun Kwon,2 Yong Joon Jeong,2 Taegeun Kim,1 Inhye Kim,3 Se Chan Kang,2 Ki-Whan Chi1 1Department of Chemistry, University of Ulsan, Ulsan, 2Department of Life Science, Gachon University, Seongnam, 3Laboratory of Bio-Resources, Yongin-si, Gyeonggi-Do, Republic of Korea *These authors contributed equally to this work Abstract: Three new large hexanuclear metalla-prisms 9–11 incorporating 1,3,5-tris(pyridin-4-ylethynyl)benzene (tpeb) 4 and one of the dinuclear arene ruthenium clips [Ru2(p-iPrC6H4Me)2(OO∩OO)][CF3SO3]2 (OO∩OO =2,5-dioxydo-1,4-benzoquinonato [dobq] 1, 5,8-dihydroxy-1,4-naphthaquinonato (donq) 2, and 6,11-dihydroxy-5,12-naphthacenedionato [dotq] 3), which encapsulate the guest molecule ellagic acid (2,3,7,8-tetrahydroxy-chromeno[5,4,3-cde]chromene-5,10-dione, 5) were prepared. All complexes were isolated as triflate salts in good yields and were fully characterized by 1H NMR spectroscopy and electrospray ionization mass spectrometry. The photophysical properties of these metalla-prisms were also investigated. Compounds 9 and 10 showed potent antioxidant activity, but 10 had the superior ORACPE value (1.30±0.020). Ellagic acid (5) and compound 11 showed weaker activity than that of Trolox. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the metalla-prism compounds exhibit anticancer properties in vitro. Compound 10 inhibited the growth of all cancer cell lines at micromolar concentrations, with the highest cytotoxicity observed against A549 human lung cancer cells (IC50 =25.9 µM). However, these compounds had a lower anti-cancer activity than that of doxorubicin. In a tumoricidal assay, ellagic acid (5) and compound 10 induced cytotoxicity in tumor cells, while doxorubicin did not. While free ellagic acid had no effect on the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein, the encapsulated metalla-prism 10 stimulated granulocyte-colony stimulating factor and reduced regulated on activation normal T cell expressed and secreted protein expression in the RAW264.7 macrophage line. Our results show that ellagic acid encapsulated in metalla-prisms inhibited cancer cells via the modulation of mRNA induction and protein expression levels of the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein in macrophages. Keywords: metalla-prism, antioxidant, tumoricidal assay, G-CSF, RantesDubey APark DWKwon JEJeong YJKim TKim IKang SCChi KWDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss Special Issue on diverse applications in Nano-Theranostics, Pp 227-240 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Dubey A
Park DW
Kwon JE
Jeong YJ
Kim T
Kim I
Kang SC
Chi KW
Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
description Abhishek Dubey,1,* Dae Won Park,2,* Jung Eun Kwon,2 Yong Joon Jeong,2 Taegeun Kim,1 Inhye Kim,3 Se Chan Kang,2 Ki-Whan Chi1 1Department of Chemistry, University of Ulsan, Ulsan, 2Department of Life Science, Gachon University, Seongnam, 3Laboratory of Bio-Resources, Yongin-si, Gyeonggi-Do, Republic of Korea *These authors contributed equally to this work Abstract: Three new large hexanuclear metalla-prisms 9–11 incorporating 1,3,5-tris(pyridin-4-ylethynyl)benzene (tpeb) 4 and one of the dinuclear arene ruthenium clips [Ru2(p-iPrC6H4Me)2(OO∩OO)][CF3SO3]2 (OO∩OO =2,5-dioxydo-1,4-benzoquinonato [dobq] 1, 5,8-dihydroxy-1,4-naphthaquinonato (donq) 2, and 6,11-dihydroxy-5,12-naphthacenedionato [dotq] 3), which encapsulate the guest molecule ellagic acid (2,3,7,8-tetrahydroxy-chromeno[5,4,3-cde]chromene-5,10-dione, 5) were prepared. All complexes were isolated as triflate salts in good yields and were fully characterized by 1H NMR spectroscopy and electrospray ionization mass spectrometry. The photophysical properties of these metalla-prisms were also investigated. Compounds 9 and 10 showed potent antioxidant activity, but 10 had the superior ORACPE value (1.30±0.020). Ellagic acid (5) and compound 11 showed weaker activity than that of Trolox. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the metalla-prism compounds exhibit anticancer properties in vitro. Compound 10 inhibited the growth of all cancer cell lines at micromolar concentrations, with the highest cytotoxicity observed against A549 human lung cancer cells (IC50 =25.9 µM). However, these compounds had a lower anti-cancer activity than that of doxorubicin. In a tumoricidal assay, ellagic acid (5) and compound 10 induced cytotoxicity in tumor cells, while doxorubicin did not. While free ellagic acid had no effect on the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein, the encapsulated metalla-prism 10 stimulated granulocyte-colony stimulating factor and reduced regulated on activation normal T cell expressed and secreted protein expression in the RAW264.7 macrophage line. Our results show that ellagic acid encapsulated in metalla-prisms inhibited cancer cells via the modulation of mRNA induction and protein expression levels of the granulocyte-colony stimulating factor and regulated on activation normal T cell expressed and secreted protein in macrophages. Keywords: metalla-prism, antioxidant, tumoricidal assay, G-CSF, Rantes
format article
author Dubey A
Park DW
Kwon JE
Jeong YJ
Kim T
Kim I
Kang SC
Chi KW
author_facet Dubey A
Park DW
Kwon JE
Jeong YJ
Kim T
Kim I
Kang SC
Chi KW
author_sort Dubey A
title Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
title_short Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
title_full Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
title_fullStr Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
title_full_unstemmed Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
title_sort investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/72a4d708df9c4fa78723bd37f44d1ccb
work_keys_str_mv AT dubeya investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT parkdw investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT kwonje investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT jeongyj investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT kimt investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT kimi investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT kangsc investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
AT chikw investigationofthebiologicalandanticancerpropertiesofellagicacidencapsulatednanosizedmetallacages
_version_ 1718401557058289664